Clark Capital Management Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Clark Capital Management Group’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-20,699	Closed	-$2.97M	–	366
2016 Q1	$2.97M	Buy	20,699 +5,295	+34%	+$752K	0.23%	117
2015 Q4	$2.38M	Buy	15,404 +3,773	+32%	+$551K	0.19%	116
2015 Q3	$1.66M	Buy	11,631 +2,280	+24%	+$319K	0.15%	141
2015 Q2	$1.34M	Buy	9,351 +2,149	+30%	+$306K	0.12%	163
2015 Q1	$1.02M	Buy	7,202 +1,448	+25%	+$223K	0.09%	178
2014 Q4	$853K	Buy	5,754 +438	+8%	+$64.4K	0.08%	159
2014 Q3	$818K	Buy	5,316 +519	+11%	+$78.1K	0.07%	145
2014 Q2	$672K	Buy	4,797 +607	+14%	+$67.4K	0.06%	157
2014 Q1	$465K	Buy	+4,190	New	+$456K	0.04%	205

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Clark Capital Management Group's TARO Position: Q2 2016 in Review

Clark Capital Management Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 20,699 shares — an estimated $2.97M sold.

Clark Capital Management Group first reported a position in TARO in Q1 2014 and held it in 9 quarters. The position peaked at $2.97M in Q1 2016. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Clark Capital Management Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Clark Capital Management Group sold 20,699 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $2.97M.
Clark Capital Management Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 9 quarters.
Clark Capital Management Group's Taro Pharmaceutical Industries Ltd. position peaked at $2.97M in Q1 2016.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Clark Capital Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.